erlotinib hydrochloride
SpainDrugs containing this active substance
-
It is used to treat advanced non-small cell lung cancer and metastatic pancreatic cancer (the latter in combination with gemcitabine).
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163,9 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat advanced non-small cell lung cancer (as initial treatment or if the disease does not change after chemotherapy) and metastatic pancreatic cancer, in combination with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27,32 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat advanced non-small cell lung cancer in adults and also for metastatic pancreatic cancer (the latter in combination with gemcitabine).
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride Igual a 109.267 mg mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat advanced non-small cell lung cancer in adults, either as initial treatment or if the disease does not change following chemotherapy. It is also prescribed for metastatic pancreatic cancer, in combination with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163.900 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat non-small cell lung cancer in adults (either as initial treatment or if the disease does not change after chemotherapy) and for metastatic pancreatic cancer, when combined with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride Igual a 27.317 mg mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat advanced non-small cell lung cancer in adults (either as initial treatment or if the disease has not progressed after chemotherapy) and metastatic pancreatic cancer, in combination with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 109,28 mg Manufacturer: Teva B.V.
-
It is used to treat non-small cell lung cancer in adults (either as initial treatment or if the disease persists after chemotherapy) and also metastatic pancreatic cancer, in combination with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163,93 mg Manufacturer: Teva B.V.
-
It is used to treat non-small cell lung cancer in adults (either as initial treatment or if the disease does not change after chemotherapy) and also for metastatic pancreatic cancer, in combination with gemcitabine.
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27,32 mg Manufacturer: Teva B.V.